Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

Molcin IV infusion

Ferron Par Pharmaceuticals

Product packaging may vary from one country to another.

Ingredients in every 250 ml

Moxifloxacin 400 mg

Each package contains

1 bottle of 250 ml

Other details

Dosage formIntravenous infusion
Flavour None

W.H.O. classification

ATC Level 1 J – Antiinfectives for systemic use
ATC Level 2 J01 – Antibacterials for Systemic Use
ATC Level 3 J01M – Quinolone Antibacterials



<span class="warning-0 warning-pregnancy">NOT RECOMMENDED</span>This item is not safe for use during pregnancy.


NOT RECOMMENDEDThis item is not safe for use during lactation.


CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.


NOT RECOMMENDEDThis item should not be used while operating heavy machinery.

Available in


Dosage information

The recommended dose for moxifloxacin is 400 mg once daily.

For treatment of complicated intraabdominal infections and complicated skin and skin structure infections requiring initial intravenous therapy followed by oral administration of 400 mg moxifloxacin tablet.

Efficacy and safety in children and adolescents have not been established.

— The infusion solution should be infused intravenously over 1 hour. Rapid intravenous infusion of moxifloxacin should be avoided.
— It can be administered directly or via a T-tube together with compatible infusion solutions.
— If moxifloxacin infusion solution is to be given with another drug, each drug should be given separately.
— Moxifloxacin intravenous solution should be inspected visually for particulate matter prior to administration and should be discarded if visible particulates are evident. Only clear solutions are to be used.

No adjustment of dosage is required in elderly patients.

No dosage adjustment is required in patients with impaired renal function (creatinine clearance < 30 ml/minute/1.73m²).


Intravenous moxifloxacin is only for patients that cannot take oral administration or have been clinically proven have to take parenteral administration. Moxifloxacin infusion 400 mg is indicated for the treatment in Adults (≥18 years of age) for the following bacterial infections:

Acute exacerbations of chronic bronchitis.
Community-acquired pneumonia.
Acute bacterial sinusitis

Complicated skin and skin structure infections which require initial parenteral therapy; followed by oral; in patients who are intolerance to alternative agents (especially penicillin allergy), and when caused by organisms known to be susceptible to moxifloxacin.

Complicated intraabdominal infections due to polymicrobial infections in patients who are intolerance to alternative agents; caused by organisms known to be susceptible to moxifloxacin.

Moxifloxacin infusion 400 mg is indicated for the treatment of the above infections if they are caused by bacteria susceptible to moxifloxacin.

Consideration should be given of official guidance on the appropriate use of antibacterial agents. Moxifloxacin may only be used on prescription and under the constant supervision doctor.